UNC Catalyst for Rare Disease
Our Vision
To promote rapid, affordable therapy for rare diseases through innovation and collaboration.
Our Mission
Innovating in target identification, new and repurposed drugs and delivery system technology. Collaborating to address specific rare diseases, product development and commercialization.
Explore Catalyst
Our Team
Anthony Hickey
Director
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
ahickey@unc.edu
Tammy Havener
Senior Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
THavener@unc.edu
Stefanie Howell
Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
sdhowell@unc.edu
Wen Yih Aw
Edward Anderson
Postdoctoral Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
edandrsn@email.unc.edu
Kathryn Hixson
Postdoctoral Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
khixson@email.unc.edu
Horacio Maldonado
Postdoctoral Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
horacio@unc.edu
Sean Ekins
Entrepreneur in Residence
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
collaborationspharma@gmail.com
Sarah Dugger
Postdoctoral Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
sdugger@email.unc.edu
Justin Wolter
Postdoctoral Research Associate
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
sdugger@email.unc.edu
Gail Moriarty
Executive Assistant
UNC Catalyst for Rare Disease
UNC Eshelman School of Pharmacy
gail_moriarty@unc.edu
Contact Catalyst
Email: unccatalyst@unc.edu
Phone: 919-445-2724
News
-
UNC Catalyst Hosts Rare Diseases Day Awareness Event
The UNC Catalyst for Rare Diseases hosted a meet-and-greet in the Genetic Medicine Building on Feb. 27 for Rare Diseases Day. Catalyst scientists provided guests an overview of the research group’s mission and rare disease projects. UNC Catalyst is a … Continued
-
Anthony Hickey Named Director of UNC Catalyst for Rare Diseases
Anthony Hickey, Ph.D., has returned to the UNC Eshelman School of Pharmacy to head up the UNC Catalyst for Rare Diseases. Hickey, a professor in the Division of Pharmacoengineering and Molecular Pharmaceutics from 1993 until 2010, returns to the School … Continued
-
Alves Wins Lush Prize for Artificial Intelligence Chemical Toxicity Research
Vinicius Alves, Ph.D., M.Sc., a postdoctoral research associate at the UNC Eshelman School of Pharmacy Catalyst for Rare Diseases, is a recipient of the 2018 Lush Prize Young Researcher award. The Lush Prize rewards initiatives across science and campaigning that … Continued